Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell Morris

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|November 11, 2010
Meaningful use updateJohn T Bigalke, Mitchell Morris
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group studyMitchell Morris, John A Blessing, Bradley J Monk, et al.
Gynecologic Oncology|April 26, 2002
Functional outcomes and complications of continent urinary diversions in patients with gynecologic malignanciesPedro T Ramirez, Susan C Modesitt, Mitchell Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01Patricia J Eifel, Kathryn Winter, Mitchell Morris, et al.
International Journal of Radiation Oncology, Biology, Physics|October 9, 2007
Are increased tumor aneuploidy and heightened cell proliferation along with heterogeneity associated with patient outcome for carcinomas of the uterine cervix? A combined analysis of subjects treated in RTOG 9001 and a single-institution trialAaron H Wolfson, Kathryn Winter, William Crook, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|November 11, 2010
Meaningful use updateJohn T Bigalke, Mitchell Morris
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group studyMitchell Morris, John A Blessing, Bradley J Monk, et al.
Gynecologic Oncology|April 26, 2002
Functional outcomes and complications of continent urinary diversions in patients with gynecologic malignanciesPedro T Ramirez, Susan C Modesitt, Mitchell Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01Patricia J Eifel, Kathryn Winter, Mitchell Morris, et al.
International Journal of Radiation Oncology, Biology, Physics|October 9, 2007
Are increased tumor aneuploidy and heightened cell proliferation along with heterogeneity associated with patient outcome for carcinomas of the uterine cervix? A combined analysis of subjects treated in RTOG 9001 and a single-institution trialAaron H Wolfson, Kathryn Winter, William Crook, et al.
Pageof 1